Our experts provide a detailed summary of Plenary Session 1 at ISPOR 2022 on the Convergence of HTA ...
Read moreWe summarise four handpicked articles from pharmaceutical, pricing and market access that are worth ...
Read moreEUCOPE and EFPIA have issued a joint statement expressing concerns regarding the implementation of t...
Read moreA cross-border alliance of health technology assessment (HTA) agencies has been announced by the Can...
Read moreWe summarise four handpicked articles from pharmaceutical, pricing and market access that are worth ...
Read moreThe short answer to the question “how important is HTA when launching a biosimilar in the EU5?” ...
Read moreWe investigate Single Technology Appraisals (STAs) conducted by NICE, comparing outcomes for monothe...
Read moreThe MHRA awards Innovation Passports to those products it deems innovative, in order for them to be ...
Read moreThe Haute Autorité de Santé (HAS), recently announced changes to the conditions in which a drug wi...
Read moreOur Market Access analysts summarise the EUnetHTA draft scoping process and provide considerations a...
Read more